Day: December 26, 2025

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Vyriad $25M Series B to take in-vivo CAR-T into clinic

Lucid Diligence Brief: Vyriad $25M Series B to take in-vivo CAR-T into clinic…

by Timos Papagatsias

Respiratory

Respiratory 2025 Review: From Symptom Control to Disease Modification

In 2025, respiratory medicine crossed a threshold: biologics entered COPD at…

by LucidQuest

Vaccines

Vaccines 2025 Review: From Emergency Platforms to Durable Public Health Assets

In 2025, vaccines moved decisively beyond the COVID-era…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.